The legacy of Vasco Maria: a life with purpose and focus on health and medicine
DOI:
https://doi.org/10.32385/rpmgf.v39i3.13843Keywords:
LegacyAbstract
Legacy has to do with everything that is built and transmitted to others, and which, due to its importance, remains current, allowing it to perpetuate itself from generation to generation over time and transforming others' lives, others' contexts, others' realities, with a purpose that can be useful to others.
Vasco António de Jesus Maria was born in Pombal on May 1, 1955, and his life path as a man and as a doctor leaves essence, value, and vision that is eternal.
Downloads
References
Jordão JG. A medicina geral e familiar: caracterização da prática e sua influência no ensino pré-graduado [dissertation]. Lisboa: Faculdade de Medicina da Universidade de Lisboa; 1995.
Başak O, Yaphe J, Spiegel W, Wilm S, Carelli F, Metsemakers JF. Early clinical exposure in medical curricula across Europe: an overview. Eur J Gen Pract. 2009;15(1):4-10.
Ellaway RH, Graves L, Cummings BA. Dimensions of integration, continuity and longitudinality in clinical clerkships. Med Educ. 2016;50(9):912-21.
Heyrman J, editor. Agenda educativa EURACT: versão Portuguesa [The EURACT educational agenda of general practice/family medicine] [Internet]. Lisboa: Associação dos Docentes e Orientadores de Medicina Geral e Familiar; 2006. Available from: http://old.apmgf.pt/ficheiros/AEE.pdf
World Health Organization. Primary care as a hub of coordination: networking within the community and with outside partners. Geneva: WHO; 2008.
Kickbusch I, Gleicher D. Governance for health in the 21st century [homepage]. Geneva: World Health Organization; 2012. Available from: https://apps.who.int/iris/handle/10665/326429
Maria VA, Pimpão MV, Carvalho ML, Sousa AE, Lucas MM, Victorino RM. Utilização de testes serológicos para detecção de infecção pelo VIH em consultas de clínica geral e em consultas hospitalares [The use of serological tests for detecting HIV infection in general clinical consultations and hospital consultations]. Acta Med Port. 1995;8(10):543-52. Portuguese
Fernandes M, Costa A, Cruz M, Ribeiro C, Rebelo L, Maria VA. Defining prescription quality indicators at primary care level in Portugal. Pharmacoepidemiol Drug Saf. 2016;25 Suppl 3:232-3.
Oliveira J, Neves I, Fernandes M, Santos O, Maria VA. Prescribing and facilitating withdrawal from benzodiazepines in primary health care. Rev Port Med Geral Fam. 2019;35(4):305-12.
Neves IT, Oliveira JS, Fernandes MC, Santos OR, Maria VA. Physicians’ beliefs and attitudes about benzodiazepines: a cross-sectional study. BMC Fam Pract. 2019;20(1):71.
Fernandes M, Neves I, Oliveira J, Santos O, Aguiar P, Atalaia P, et al. Discontinuation of chronic benzodiazepine use in primary care: a nonrandomized intervention. Fam Pract. 2022;39(2):241-8.
Azevedo R, Vinagre L, Marques D, Damásio C, Sá R, Jorge L, et al. The impact of rapid antigen detection test (RADT) for group A streptococcus on the antibiotic prescription: an observational study from a primary care setting in Lisbon. Rev Port Med Geral Fam. 2023;39(2):121-8.
Maria VA. O medicamento genérico: história de um percurso bem sucedido. In: Duarte AG, editor. INFARMED 15 anos: olhar o passado, projectar o futuro. Lisboa: INFARMED; 2008. p. 89-92.
Maria VA. A regulamentação do medicamento na era da globalização: tendências. In: Duarte AG, editor. INFARMED 15 anos: olhar o passado, projectar o futuro. Lisboa: INFARMED; 2008. p. 135-9.
Victorino RM, Maria VA. Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis. Diagn Immunol. 1985;3(4):171-81.
Victorino RM, Maria VA. Drug-induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor. Lancet. 1986;1(8491):1209-10.
Victorino RM, Maria VA, Correia AP, Moura C. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization. Arch Intern Med. 1987;147(5):987-9.
Maria VA, Silva JA, Victorino RM. Agranulocytosis and liver damage associated with pyrazinobutazone with evidence for an immunological mechanism. J Rheumatol. 1989;16(11):1484-5.
Maria VA, Pinto LA, Victorino RM. Inhibition of lymphocyte proliferation induced in vitro by microbial antigens in HIV-infected subjects. J Med Virol. 1991;35(4):241-5.
Victorino RM, Maria VA, Pinto LA. Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitization. Clin Exp Immunol. 1992;87(1):132-7.
Maria VA, Victorino RM. Hypersensitivity immune reaction as a mechanism for dilevalol-associated hepatitis. Ann Pharmacother. 1992;26(7-8):924-6.
Maria VA, Pinto L, Victorino RM. Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol. 1994;21(2):151-8.
Maria VA, Victorino RM. Lymphocyte proliferative response to drugs: analysis of the value of a 24-well lymphocyte culture system. Toxic in Vitro. 1994;8(5):1041-4.
Maria VA, Victorino RM. Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut. 1997;41(4):534-40.
Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997;26(3):664-9.
Maria VA, Victorino RM. Immunological investigation in hepatic drug reactions. J Clin Exp Allergy. 1998;28 Suppl 4:71-7.
Bartle WR. Diagnostic value of T cell reactivity in drug induced hepatitis. Gut. 1998;43(5):730-1.
Maria V, Albuquerque A, Loureiro A, Sousa A, Victorino R. Severe cholestatic hepatitis induced by pyritinol. BMJ. 2004;328(7439):572-4.
Silva-Lima B, Carlson D, Jones DR, Laurie D, Stahl E, Maria V, et al. The European and American use of exploratory approaches for first-in-human studies. Clin Transl Sci. 2010;3(1):38-41.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Portuguese Journal of Family Medicine and General Practice

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.